Squarepoint Ops LLC Ligand Pharmaceuticals Inc Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$61.72 - $96.74 $541,593 - $848,893	-8,775 Reduced 74.16%	3,058 $204,000
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $118 - $1.27 Million	11,833 New	11,833 $1.02 Million
Q2 2022 Aug 15, 2022	SELL	$74.52 - $117.06 $586,174 - $920,793	-7,866 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$94.99 - $151.56 $623,039 - $994,082	6,559 Added 501.84%	7,866 $885,000
Q4 2021 Feb 14, 2022	SELL	$127.69 - $165.85 $392,519 - $509,822	-3,074 Reduced 70.17%	1,307 $202,000
Q3 2021 Nov 15, 2021	BUY	$102.33 - $144.73 $448,307 - $634,062	4,381 New	4,381 $610,000
Q2 2021 Aug 16, 2021	SELL	$113.03 - $155.64 $518,694 - $714,231	-4,589 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$99.52 - $215.83 $96,534 - $209,355	970 Added 26.8%	4,589 $700,000
Q4 2020 Feb 16, 2021	SELL	$80.55 - $106.05 $507,142 - $667,690	-6,296 Reduced 63.5%	3,619 $360,000
Q3 2020 Nov 16, 2020	BUY	$89.56 - $126.72 $35,644 - $50,434	398 Added 4.18%	9,915 $945,000
Q2 2020 Aug 14, 2020	BUY	$68.28 - $123.65 $649,820 - $1.18 Million	9,517 New	9,517 $1.06 Million
Q1 2020 May 15, 2020	SELL	$63.37 - $107.88 $532,878 - $907,162	-8,409 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$96.94 - $113.59 $815,168 - $955,178	8,409 New	8,409 $877,000
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $695,347 - $968,729	-8,062 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$107.38 - $129.34 $601,757 - $724,821	-5,604 Reduced 41.01%	8,062 $920,000
Q1 2019 May 15, 2019	SELL	$105.93 - $142.47 $1.07 Million - $1.44 Million	-10,140 Reduced 42.59%	13,666 $1.72 Million
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $2.74 Million - $5.82 Million	21,384 Added 882.91%	23,806 $3.23 Million
Q3 2018 Nov 14, 2018	BUY	$211.18 - $274.49 $193,440 - $251,432	916 Added 60.82%	2,422 $665,000
Q2 2018 Aug 14, 2018	BUY	$150.77 - $207.98 $227,059 - $313,217	1,506 New	1,506 $312,000
Q4 2017 Feb 14, 2018	SELL	$128.36 - $147.04 $333,350 - $381,862	-2,597 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$120.91 - $137.94 $314,003 - $358,230	2,597	2,597 $354,000

Others Institutions Holding LGND

# of Institutions

255

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.86B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account